WebMay 20, 2024 · Chemotherapy resistance is another issue for the refractory tumors. 92 The RAS–RAF–MEK–ERK pathway is widely activated in tumors, and high frequency of KRAS and BRAF mutations are observed in pancreatic cancer, melanoma and lung cancer. 93, 107, 108 A recent study has declared the association between RAS–RAF–MEK–ERK … WebMar 7, 2024 · In a comparison of ERK targeting strategies, accumulating evidence demonstrated that activating ERK could take effect in cancer treatments [ 34, 35, 36 ]. Additionally, ERK signaling has also been involved in cell death induced by anti-cancer compounds including quercetin [ 37 ], betulinic acid [ 38] and miltefosine [ 39 ].
TAF15 promotes cell proliferation, migration and invasion of …
WebJan 19, 2024 · Background BRAFV600E mutation is the most common mutation in thyroid cancer. It strongly activates MAPK/ERK pathway and indicates an invasive subtype of thyroid cancer. PLX4032 is a selective oral inhibitor of the BRAFV600 kinase although with limited effect in treating this panel of thyroid cancer, due to the feedback activation of … WebApr 12, 2024 · Furthermore, knockdown of HIGD2A markedly attenuated the activation of the MAPK/ERK pathway. HIGD2A promoted liver cancer cell growth by fueling mitochondrial ATP synthesis and activating the MAPK/ERK pathway, suggested that targeting HIGD2A may represent a new strategy for HCC therapy. cheryl robertson md cardiology
Vitamin C sensitizes BRAFV600E thyroid cancer to PLX4032 via …
WebJan 16, 2014 · In mice, ERK kinases are essential for survival, complicating the efforts of testing their role in tumorigenesis . Interestingly, in KRAS-driven lung cancer, … WebApr 10, 2024 · However, the role and molecular mechanism of TAF15 in gastric cancer (GC) progression are still unknown. In this study, we found that TAF15 was signif … TAF15 promotes cell proliferation, migration and invasion of gastric cancer via activation of the RAF1/MEK/ERK signalling pathway WebSep 10, 2024 · The AKT and ERK signaling are both aberrantly activated in a wide range of human cancers and have long been targeted for cancer therapy, but the clinical benefits of these targeted therapies have been limited due to complex cross-talk. Novel strategies, such as AKT/ERK dual inhibitors, may be needed. Keywords: MAPK/ERK pathway; ONC201; … cheryl roberts seattle